Summary
This paper discusses the potential of photoreceptor cell-replacement for repair in retinitis pigmentosa, a primary cause of inherited retinal blindness, using human pluripotent stem cells.
Categories
Eye health: The paper discusses the use of human pluripotent stem cells for photoreceptor replacement therapies aimed at photoreceptor regeneration in retinal disease, specifically retinitis pigmentosa.
Aging: The paper discusses retinitis pigmentosa, a degenerative eye disease that typically manifests in adulthood.
Phototherapy: The paper discusses the potential for photoreceptor cell-replacement therapy in treating retinitis pigmentosa.
Author(s)
AO Barnea-Cramer, W Wang, SJ Lu, MS Singh
Publication Year
2016
Number of Citations
153
Related Publications
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
- Combinatorial effects of alpha-and gamma-protocadherins on neuronal survival and dendritic self-avoidance
- Quadrant field pupillometry detects melanopsin dysfunction in glaucoma suspects and early glaucoma
Phototherapy
- Phototransduction by retinal ganglion cells that set the circadian clock
- Strange vision: ganglion cells as circadian photoreceptors
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
- Short‐wavelength enrichment of polychromatic light enhances human melatonin suppression potency
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease